돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 9869779생성일: 2026년 10월 26일

Ki-20227

Ki20227 · CS-1094 · Ki20227 ,S7688 · KI 20227 · Ki20227, 10 mM in DMSO · KI-20227 · N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea · 1-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)-2-methoxyphenyl)-3-(1-(thiazol-2-yl)ethyl)urea

https://huagongshe.com/ko/chemical/9869779

Ki-20227 분자 구조식

식별자 및 물리적 특성

CAS No.623142-96-1
분자식C24H24N4O5S
평균 분자량480.5 g/mol
단동위원소 질량480.14674105 g/mol
SMILESCOc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1
InChIKeySHPFDGWALWEPGS-UHFFFAOYSA-N
PubChem CID9869779
ChEMBLCHEMBL1908396
DTXSIDDTXSID80432108

화학 및 물리적 성질

XLogP3.6
극성 표면적132
수소 결합 공여자 수2
수소 결합 수용자 수8
회전 가능 결합 수8
무거운 원자 수34
형식 전하0
복잡도661
끓는 점621.8±55.0 °C(Predicted)
밀도1.327
저장 조건Sealed in dry,Store in freezer, under -20°C
용해도≥48.1 mg/mL in DMSOinsoluble in H2O≥8.6 mg/mL in EtOH with gentle warming and ultrasonic
물리적 상태갈색 가루.
pKa(산도 계수)12.03±0.46(Predicted)
색상Off-white to pink

용도

개요

Ki20227 is an inhibitor of macrophage colony stimulating factor 1 (CSF1) receptor tyrosine kinase (c-Fms; IC50 = 2 nM). It inhibits CSF1-dependent c-Fms phosphorylation in a dose-dependent manner in RAW264.7 cells and reduces CSF1-dependent growth of M-NFS-60 cells (IC50 = 14 nM). Ki20227 suppresses development of TRAP-positive osteoclast-like cells from murine bone marrow (IC50 = 40 nM) and decreases the number and area of osteolytic lesions on femurs and tibiae in a murine A375 subcutaneous xenograft model. Ki20227 also reduces TNF-α infiltration and osteolytic bone destruction in a collagen-induced arthritis (CIA) mouse model.

용도

Ki 20227 is a c-fms tyrosine kinase inhibitor, which suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.